• New Versant Ventures startup goes ‘gutless' for next-generation gene delivery

    1 month ago - By MedCity News

    Vector BioPharma has launched from the biotech startup incubator of Versant Ventures, which is backing the company with a $30 million Series A financing. Vector is developing virus-like particles with the capability to deliver large payloads of genetic medicines to a wide range of tissues.
    Read more ...